Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma (Q81916869)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 September 2008
edit
Language Label Description Also known as
English
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma
scientific article published on 01 September 2008

    Statements

    title
    Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    18764869
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18764869%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    13 January 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q81916869&oldid=1561082184"